All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • XER-001Phase 21 trial

    Xerient Pharma · Locally Advanced Pancreatic Adenocarcinoma, Locally Advanced Pancreas Cancer, Locally Advanced Pancreatic Ductal Adenocarcinoma

  • XJN010Phase 21 trial

    Guangzhou Novaken Pharm Co., Ltd. · Parkinson Disease

  • XmAb942Phase 21 trial

    Xencor, Inc. · Ulcerative Colitis (UC)

  • XNW29016PARGiPhase 21 trial

    Evopoint Biosciences Inc. · Tumor, Solid

  • XNW34017Phase 21 trial

    Evopoint Biosciences Inc. · Advanced Solid Tumors

  • XP-102Phase 21 trial

    Xynomic Pharmaceuticals, Inc. · Cancer, BRAF V600 Mutation, Melanoma

  • XPro1595INB03, XProPhase 21 trial

    Inmune Bio, Inc. · Alzheimer Disease, Dementia, Brain Diseases

  • XS-03Phase 21 trial

    Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. · Colorectal Cancer, Metastatic Colorectal Cancer With RAS Mutation

  • XTX202Phase 21 trial

    Xilio Development, Inc. · Advanced Solid Tumor

  • XTX301Phase 21 trial

    Xilio Development, Inc. · Advanced Solid Tumor

  • XTX501Phase 21 trial

    Xilio Development, Inc. · Metastatic NSCLC - Non-Small Cell Lung Cancer, Advanced Solid Tumor

  • XY03-EAper dosePhase 21 trial

    Shijiazhuang Yiling Pharmaceutical Co. Ltd · Stroke, Ischemic

  • XYA02Phase 21 trial

    XYone Therapeutics, Inc · MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer

  • XZP-5955Phase 21 trial

    Xuanzhu Biopharmaceutical Co., Ltd. · Locally Advanced or Metastatic Solid Tumors, Locally Advanced or Metastatic Non-small Cell Lung Cancer

  • Y101DPhase 21 trial

    Wuhan YZY Biopharma Co., Ltd. · Advanced Pancreatic Adenocarcinoma

  • YA-101Phase 21 trial

    Dasher Neuroscience Inc. · Multiple System Atrophy

  • YCT-529Phase 21 trial

    YourChoice Therapeutics, Inc. · Male Contraception

  • YD0743Phase 21 trial

    Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. · Sepsis

  • YH32364Phase 21 trial

    Yuhan Corporation · EGFR Overexpression, Locally Advanced Solid Tumor, Metastatic Solid Tumor

  • YH32367Phase 21 trial

    Yuhan Corporation · HER2-Positive Solid Tumor

  • YH42946Phase 21 trial

    Yuhan Corporation · NSCLC (Non-small Cell Lung Cancer), Solid Tumor

  • YKST02Phase 21 trial

    Excyte Biopharma Ltd · Relapsed or Refractory Multiple Myeloma (RRMM)

  • YKYY013Phase 21 trial

    Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. · HBV (Hepatitis B Virus)

  • YL-13027Phase 21 trial

    Shanghai YingLi Pharmaceutical Co. Ltd. · Metastatic Pancreatic Cancer

  • YMI024Phase 21 trial

    Novartis · Coronary Artery Disease

  • YR001Phase 21 trial

    Hangzhou Yirui Pharmaceutical Technology Co., Ltd · Atopic Dermatitis

  • YY003Phase 21 trial

    Chongqing Claruvis Pharmaceutical Co., Ltd. · Moderate to Severe Glabellar Lines

  • YZJ-4729Phase 21 trial

    Shanghai Haiyan Pharmaceutical Technology Co., Ltd. · Pain

  • ZED1227Phase 21 trial

    Dr. Falk Pharma GmbH · Celiac Disease

  • zetomipzomibKZR-616, zetomipzomib in open-label extensionPhase 21 trial

    Kezar Life Sciences, Inc. · Autoimmune Hepatitis

  • zevor-celCAR-BCMA T CellPhase 21 trial

    CARsgen Therapeutics Co., Ltd. · Multiple Myeloma

  • ZL-85FAPhase 21 trial

    Chengdu Zenitar Biomedical Technology Co., Ltd · Advanced Solid Tumor

  • ZSP1601Phase 21 trial

    Guangdong Raynovent Biotech Co., Ltd · Nonalcoholic Steatohepatitis (NASH)

  • ZT-01Phase 21 trial

    Zucara Therapeutics Inc. · Type 1 Diabetes Mellitus With Hypoglycemia

  • ZT006Phase 21 trial

    Beijing QL Biopharmaceutical Co.,Ltd · Overweight , Obesity

NewerPage 74 of 74

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.